Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 12, 2019

SELL
$61.87 - $69.38 $309,350 - $346,900
-5,000 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$60.54 - $79.0 $302,700 - $395,000
5,000 New
5,000 $313,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $113B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Community Capital Management, LLC Portfolio

Follow Community Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Community Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Community Capital Management, LLC with notifications on news.